Stock

Chemomab Therapeutics Ltd. CMMB

$1.39-1.77%

All stocks Create account to unlock

Overview

CMMB market data

Price History

CMMB price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for CMMB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

Chemomab Therapeutics, Scipher Medicine Strike All-Stock Merger Agreement; Combined Entity Expected To Operate Under Scipher Medicine Name, SCIP Ticker On Nasdaq · Jul 8, 2026, 11:45 AM

Chemomab Therapeutics Q1 EPS $(0.24) Beats $(0.31) Estimate · May 14, 2026, 12:33 PM

Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update · May 14, 2026, 12:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock